FDA Approves First Generic Pimobendan for Management of Congestive Heart Failure in Dogs
Today the U.S. Food and Drug Administration approved Pimomedin (pimobendan) chewable tablets for the management of the signs of mild, moderate, or severe congestive heart failure in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). Pimomedin is indicated for use with concurrent therapy for congestive heart failure (e.g., furosemide, etc.) as appropriate on a case-by-case basis.
FDA apDA Approves DuOtic Gel: A New Frontier in Treating Yeast-Only Otitis Externa in Dogsproves new otic for yeast
DuOtic is the first FDA-approved animal drug intended to treat yeast-only otitis externa in dogs. DuOtic is also the first otic drug intended to treat otitis externa that does not contain an antibiotic. This allows veterinarians to focus treatment and avoid using antibiotics when dogs have diagnosed yeast-only ear infections.
DuOtic is a fixed combination of the two active substances: terbinafine and betamethasone acetate. Terbinafine is an antifungal and is commonly used in human medicine to treat athlete’s foot. Betamethasone acetate is a glucocorticosteroid with anti-inflammatory activity.